Karandikars Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 17 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 30.27%
- Profit Growth 51.92%
- Ebitda 52.80%
- Net Worth -34.10%
- Total Assets -1.83%
About Karandikars Pharmachem
Karandikars Pharmachem Private Limited (KPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 February 2017 (Eight years 17 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satyajit Karandikar and Bhima Kale serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2017PTC290922
- Company No.
290922
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Karandikars Pharmachem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyajit Karandikar  | Director | 08-Feb-2017 | Current |
| Bhima Kale | Director | 30-May-2017 | Current |
Financial Performance of Karandikars Pharmachem.
Karandikars Pharmachem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.27% increase. The company also saw a substantial improvement in profitability, with a 51.92% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karandikars Pharmachem?
In 2022, Karandikars Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Karandikars Orgochem Private LimitedSatyajit Karandikar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Karandikars Pharmachem?
Unlock and access historical data on people associated with Karandikars Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karandikars Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karandikars Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
